NextCure, Inc. Files 8-K Report
Ticker: NXTC · Form: 8-K · Filed: Jul 10, 2025 · CIK: 1661059
| Field | Detail |
|---|---|
| Company | Nextcure, Inc. (NXTC) |
| Form Type | 8-K |
| Filed Date | Jul 10, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, 8-k, routine-update
Related Tickers: NCURE
TL;DR
NextCure filed a routine 8-K, no major news.
AI Summary
On July 10, 2025, NextCure, Inc. filed an 8-K report. The filing indicates that the company is providing information under "Other Events" and is not announcing any specific material events like acquisitions, financings, or significant operational changes. The report confirms the company's name, incorporation details, and contact information.
Why It Matters
This filing serves as a routine update to the SEC, confirming NextCure, Inc.'s ongoing reporting status and providing basic company information without disclosing new material events.
Risk Assessment
Risk Level: low — The filing is a standard procedural update and does not contain information that would immediately impact the company's stock price or operations.
Key Players & Entities
- NextCure, Inc. (company) — Registrant
- July 10, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- 47-5231247 (identifier) — IRS Employer Identification No.
- Beltsville, Maryland (location) — Address of principal executive offices
- 240-399-4900 (phone_number) — Registrant's telephone number
FAQ
What is the primary purpose of this 8-K filing by NextCure, Inc.?
The primary purpose of this 8-K filing is to report under "Other Events" and to provide updated or confirmed company information as of July 10, 2025, without announcing specific material events.
What is the date of the earliest event reported in this filing?
The date of the earliest event reported in this filing is July 10, 2025.
In which state is NextCure, Inc. incorporated?
NextCure, Inc. is incorporated in Delaware.
What is the principal executive office address for NextCure, Inc.?
The principal executive office address for NextCure, Inc. is 9000 Virginia Manor Road, Suite 200, Beltsville, Maryland 20705.
Does this filing announce any specific material events such as an acquisition or financing?
No, this filing is categorized under "Other Events" and does not announce any specific material events like acquisitions, financings, or significant operational changes.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 10, 2025 regarding NextCure, Inc. (NXTC).